Slow adoption of helpful heart failure drug

Published: February, 2010

Many people who could benefit from spironolactone aren't getting it.

In 1999, a large clinical trial showed that a drug called spironolactone (spih-row-noe-LACK-tone) could improve symptoms and lengthen life in some people with heart failure. More than 10 years later, only a minority of those who could benefit from the drug are taking it, even though it is inexpensive and guidelines for treating heart failure recommend its use.

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »